Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to $2.4 million.

  • CorMedix's Other Working Capital Changes fell 297.52% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 45.20%. This contributed to the annual value of $2.4 million for FY2024, which is 299.22% up from last year.
  • Latest data reveals that CorMedix reported Other Working Capital Changes of $2.4 million as of FY2024, which was up 299.22% from $600,983 recorded in FY2023.
  • In the past 5 years, CorMedix's Other Working Capital Changes registered a high of $2.4 million during FY2024, and its lowest value of $6,891 during FY2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was $600,983 (2023), whereas its average is $1.0 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 3,498.91% in 2021, then tumbled by 87.11% in 2022.
  • Over the past 5 years, CorMedix's Other Working Capital Changes (Yearly) stood at $6,891 in 2020, then soared by 3,498.91% to $248,001 in 2021, then slumped by 87.11% to $31,955 in 2022, then surged by 1,780.72% to $600,983 in 2023, then spiked by 299.22% to $2.4 million in 2024.